Fertility experts urge UK to adopt new DNA screening for IVF embryos
By Nicola Davis,
The Guardian
| 07. 04. 2016
A new technique to genetically screen IVF embryos should be considered for use in the UK, fertility experts say. The call comes after research revealed it could help doctors select embryos that have the best of chance of leading to a pregnancy.
Pre-implantation genetic screening (PGS) is more common in the US than the UK, and is used by doctors to flag up embryos with an abnormal number of chromosomes - the main reason why embryos fail to implant in the womb.
But other factors also affect whether an embryo will implant: around a third of embryos with the correct number of chromosomes also fail to lead to a pregnancy when transferred to the womb.
Intriguingly, scientists have recently found that many of these apparently healthy embryos have something in common: they have increased levels of the DNA that is found within mitochondria - the tiny energy-generating structures that sit inside cells. The discovery, scientists say, offers a new tool for genetically screening embryos with the technique, known as mitochondrial DNA quantification, recently made available in the US.
Now fertility...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
